Search Results - Dull, P.M

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Safety and immunogenicity of one dose of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, when administered to adolescents concomitantly or sequentially with Tdap and HPV vaccines

    Safety and immunogenicity of one dose of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, when administered to adolescents concomitantly or sequen... by Arguedas, A, Soley, C, Loaiza, C, Rincon, G, Guevara, S, Perez, A, Porras, W, Alvarado, O, Aguilar, L, Abdelnour, A, Grunwald, U, Bedell, L, Anemona, A, Dull, P.M

    Published in Vaccine
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Immunogenicity and tolerability of a quadrivalent meningococcal glycoconjugate vaccine in children 2–10 years of age

    Immunogenicity and tolerability of a quadrivalent meningococcal glycoconjugate vaccine in children 2–10 years of age by Black, S, Klein, N.P, Shah, J, Bedell, L, Karsten, A, Dull, P.M

    Published in Vaccine
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Safety and immunogenicity of an investigational quadrivalent meningococcal CRM197 conjugate vaccine, MenACWY-CRM, compared with licensed vaccines in adults in Latin America

    Safety and immunogenicity of an investigational quadrivalent meningococcal CRM197 conjugate vaccine, MenACWY-CRM, compared with licensed vaccines in adults in Latin America by Stamboulian, D, Lopardo, G, Lopez, P, Cortes-Barbosa, C, Valencia, A, Bedell, L, Karsten, A, Dull, P.M

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Safety and immunogenicity of an investigational quadrivalent meningococcal CRM 197 conjugate vaccine, MenACWY-CRM, compared with licensed vaccines in adults in Latin America

    Safety and immunogenicity of an investigational quadrivalent meningococcal CRM 197 conjugate vaccine, MenACWY-CRM, compared with licensed vaccines in adults in Latin America by Stamboulian, D., Lopardo, G., Lopez, P., Cortes-Barbosa, C., Valencia, A., Bedell, L., Karsten, A., Dull, P.M.

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: